| 摘要 |
Certain cells, including types of cancer cells such as prostate cancer, are capable of expressing P-type ATPase-like (ATPHy1) mRNA and protein. Targeting using ATPHy1 polypeptides, nucleic acids encoding for ATPHy1 polypeptides and anti-ATPHy1 antibodies provides a method of killing or inhibiting that growth of cancer cells that express the ATPHy1 protein. Methods of therapy and diagnosis of disorders associated with ATPHy1 protein-expressing cells, such as breast, colon, lung, and prostate cancer, are described. |
